+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hemophilia Treatment Drugs Market by Product Type, by Disease Type, and by Distribution Channel - Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

  • ID: 4853781
  • Report
  • July 2018
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

The report covers forecast and analysis for the hemophilia treatment drugs market on a global and regional level. The study provides historical data from 2015 to 2017 along with the forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the hemophilia treatment drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hemophilia treatment drugs market on a global level.

In order to give the users of this report a comprehensive view on the hemophilia treatment drugs market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product and regional expansion of major participants involved in the market.

The study provides a decisive view on the hemophilia treatment drugs market by segmenting it on the basis of product type, disease type, distribution channel, and region. All the segments have been analyzed based on present and the future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further categorization into major countries including the U.S., the UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for hemophilia treatment drugs market based on all segments in all the regions and countries.

The report also includes detailed profiles of end players such as Shire Plc., Novo Nordisk A/S, Pfizer, Bayer AG, CSL Ltd., Biogen, and others.

This report segments the global hemophilia treatment drugs market as follows:

Global Hemophilia Treatment Drugs Market: Product Type Segment Analysis

  • Recombinant Coagulation Factor Concentrates
  • Plasma Derived Coagulation Factor Concentrates
  • Desmopressin
  • Antifibrinolytic Agents

Global Hemophilia Treatment Drugs Market: Disease Type Segment Analysis

  • Hemophilia A
  • Hemophilia B
  • Others

Global Hemophilia Treatment Drugs Market: Distribution Channel Segment Analysis

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

Global Hemophilia Treatment Drugs Market: Regional Segment Analysis

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global hemophilia treatment drugs market, 2015 - 2024 (USD Billion)
    • 2.2. Global hemophilia treatment drugs market: Snapshot
  • Chapter 3. Hemophilia Treatment Drugs Market - Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global hemophilia treatment drugs market drivers: Impact analysis
      • 3.2.2. Increasing prevalence of bleeding disorders
    • 3.3. Market Restraints
      • 3.3.1. Global hemophilia treatment drugs market restraints: Impact analysis
      • 3.3.2. Inadequate trough levels
    • 3.4. Opportunities
      • 3.4.1. Development of new drugs
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product type segment
      • 3.6.2. Market attractiveness analysis, by disease type segment
      • 3.6.3. Market attractiveness analysis, by distribution channel segment
      • 3.6.4. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Hemophilia Treatment Drugs Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global hemophilia treatment drugs market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Hemophilia Treatment Drugs Market - Product Type Segment Analysis
    • 5.1. Global hemophilia treatment drugs market: Product Type overview
      • 5.1.1. Global hemophilia treatment drugs market revenue share, by product type, 2017 and 2024
    • 5.2. Recombinant Coagulation Factor Concentrates
      • 5.2.1. Global hemophilia treatment drugs market for recombinant coagulation factor concentrates, 2015 - 2024 (USD Billion)
    • 5.3. Plasma Derived Coagulation Factor Concentrates
      • 5.3.1. Global hemophilia treatment drugs market for plasma derived coagulation factor concentrates, 2015 - 2024 (USD Billion)
    • 5.4. Desmopressin
      • 5.4.1. Global hemophilia treatment drugs market for desmopressin, 2015 - 2024 (USD Billion)
    • 5.5. Antifibrinolytic Agents
      • 5.5.1. Global hemophilia treatment drugs market for antifibrinolytic agents, 2015 - 2024 (USD Billion)
  • Chapter 6. Global Hemophilia Treatment Drugs Market - Disease Type Segment Analysis
    • 6.1. Global hemophilia treatment drugs market: Disease type overview
      • 6.1.1. Global hemophilia treatment drugs market revenue share, by disease type, 2017 and 2024
    • 6.2. Hemophilia A
      • 6.2.1. Global hemophilia treatment drugs market by hemophilia A, 2015 - 2024 (USD Billion)
    • 6.3. Hemophilia B
      • 6.3.1. Global hemophilia treatment drugs market by hemophilia B, 2015 - 2024 (USD Billion)
    • 6.4. Others
      • 6.4.1. Global hemophilia treatment drugs market by other disease types, 2015 - 2024 (USD Billion)
  • Chapter 7. Global Hemophilia Treatment Drugs Market - Distribution Channel Segment Analysis
    • 7.1. Global hemophilia treatment drugs market: Distribution channel overview
      • 7.1.1. Global hemophilia treatment drugs market revenue share, by distribution channel, 2017 and 2024
    • 7.2. Hospital Pharmacies
      • 7.2.1. Global hemophilia treatment drugs market for hospital pharmacies, 2015 - 2024 (USD Billion)
    • 7.3. Retail Pharmacies
      • 7.3.1. Global hemophilia treatment drugs market for retail pharmacies, 2015 - 2024 (USD Billion)
    • 7.4. E-Commerce
      • 7.4.1. Global hemophilia treatment drugs market for e-commerce, 2015 - 2024 (USD Billion)
  • Chapter 8. Global Hemophilia Treatment Drugs Market - Regional Segment Analysis
    • 8.1. Global hemophilia treatment drugs market: Regional overview
      • 8.1.1. Global hemophilia treatment drugs market revenue share, by region, 2017 and 2024
    • 8.2. North America
      • 8.2.1. North America hemophilia treatment drugs market, 2015 - 2024 (USD Billion)
      • 8.2.2. North America hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
      • 8.2.3. North America hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
      • 8.2.4. North America hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 8.2.5. U.S.
        • 8.2.5.1. U.S. hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.2.5.2. U.S. hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 8.2.5.3. U.S. hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.2.6.2. Rest of North America hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 8.2.6.3. Rest of North America hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe hemophilia treatment drugs market, 2015 - 2024 (USD Billion)
      • 8.3.2. Europe hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
      • 8.3.3. Europe hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
      • 8.3.4. Europe hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.3.5.2. UK hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 8.3.5.3. UK hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 8.3.6. Germany
        • 8.3.6.1. Germany hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.3.6.2. Germany hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 8.3.6.3. Germany hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 8.3.7. France
        • 8.3.7.1. France hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.3.7.2. France hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 8.3.7.3. France hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.3.8.2. Rest of Europe hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 8.3.8.3. Rest of Europe hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific hemophilia treatment drugs market, 2015 - 2024 (USD Billion)
      • 8.4.2. Asia Pacific hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
      • 8.4.3. Asia Pacific hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
      • 8.4.4. Asia Pacific hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.4.5.2. China hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 8.4.5.3. China hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.4.6.2. Japan hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 8.4.6.3. Japan hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.4.7.2. India hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 8.4.7.3. India hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.4.8.2. Rest of Asia Pacific hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 8.4.8.3. Rest of Asia Pacific hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America hemophilia treatment drugs market, 2015 - 2024 (USD Billion)
      • 8.5.2. Latin America hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
      • 8.5.3. Latin America hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
      • 8.5.4. Latin America hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.5.5.2. Brazil hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 8.5.5.3. Brazil hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.5.6.2. Rest of Latin America hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 8.5.6.3. Rest of Latin America hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa hemophilia treatment drugs market, 2015 - 2024 (USD Billion)
      • 8.6.2. Middle East and Africa hemophilia treatment drugs market revenue, by product type, 2015 - 2024 (USD Billion)
      • 8.6.3. Middle East and Africa hemophilia treatment drugs market revenue, by disease type, 2015 - 2024 (USD Billion)
      • 8.6.4. Middle East and Africa hemophilia treatment drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
  • Chapter 9. Company Profile
    • 9.1. Shire PLC
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Novo Nordisk A/S
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Pfizer
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Bayer AG
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. CSL Ltd.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. Biogen
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll